Patent 7709493 was granted and assigned to Lexicon Pharmaceuticals, Inc. on May, 2010 by the United States Patent and Trademark Office.
Compounds of formula I are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and/or manage diseases and disorders: